High-grade Serous Ovarian Carcinoma (HGSOC)
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| bms-986463 | BRISTOL MYERS SQUIBB CO (BMY) |
Frequently asked questions
How many drugs are in development for High-grade Serous Ovarian Carcinoma (HGSOC)?
BioSniper tracks 1 drug in development for High-grade Serous Ovarian Carcinoma (HGSOC) across 1 company.
How many clinical trials target High-grade Serous Ovarian Carcinoma (HGSOC)?
There are 2 clinical trials targeting High-grade Serous Ovarian Carcinoma (HGSOC) tracked by BioSniper.
Deep-dive into High-grade Serous Ovarian Carcinoma (HGSOC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis